United Therapeutics appoints Victor Dzau, former National Academy of Medicine President, to Board

Filed July 23, 2026 · Period ending July 22, 2026 · ~1 min read

Key Changes

• medium

  Board expanded to 13 members with appointment of Victor Dzau, M.D., who recently completed 12-year tenure as President of the National Academy of Medicine and held leadership roles at Duke, Harvard, and Stanford.

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
• medium

  Appointment described as part of ongoing Board refreshment initiative to provide oversight as company works on transforming patient care and developing transplantable organs.

  Exhibit 99.1 view on EDGAR →
• low

  Dr. Dzau received standard director compensation: 730 restricted stock units and 2,300 stock options (initial grant plus pro-rata for remainder of 2026-2027 Board service year).

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →